The spectrum of GATA2 deficiency syndrome
Top Cited Papers
Open Access
- 30 March 2023
- journal article
- review article
- Published by American Society of Hematology in Blood
- Vol. 141 (13) , 1524-1532
Abstract
Inherited or de novo germ line heterozygous mutations in the gene encoding the transcription factor GATA2 lead to its deficiency. This results in a constellation of clinical features including nontuberculous mycobacterial, bacterial, fungal, and human papillomavirus infections, lymphedema, pulmonary alveolar proteinosis, and myelodysplasia. The onset, or even the presence, of disease is highly variable, even in kindreds with the identical mutation in GATA2. The clinical manifestations result from the loss of a multilineage progenitor that gives rise to B lymphocytes, monocytes, natural killer cells, and dendritic cells, leading to cytopenias of these lineages and subsequent infections. The bone marrow failure is typically characterized by hypocellularity. Dysplasia may either be absent or subtle but typically evolves into multilineage dysplasia with prominent dysmegakaryopoiesis, followed in some instances by progression to myeloid malignancies, specifically myelodysplastic syndrome, acute myelogenous leukemia, and chronic myelomonocytic leukemia. The latter 3 malignancies often occur in the setting of monosomy 7, trisomy 8, and acquired mutations in ASXL1 or in STAG2. Importantly, myeloid malignancy may represent the primary presentation of disease without recognition of other syndromic features. Allogeneic hematopoietic stem cell transplantation (HSCT) results in reversal of the phenotype. There remain important unanswered questions in GATA2 deficiency, including the following: (1) Why do some family members remain asymptomatic despite harboring deleterious mutations in GATA2? (2) What are the genetic changes that lead to myeloid progression? (3) What causes the apparent genetic anticipation? (4) What is the role of preemptive HSCT?Keywords
This publication has 69 references indexed in Scilit:
- Cis-element mutated in GATA2-dependent immunodeficiency governs hematopoiesis and vascular integrityJournal of Clinical Investigation, 2012
- Conditional Gata2 inactivation results in HSC loss and lymphatic mispatterningJournal of Clinical Investigation, 2012
- The genetic basis of early T-cell precursor acute lymphoblastic leukaemiaNature, 2012
- Successful allogeneic hematopoietic stem cell transplantation for GATA2 deficiencyBlood, 2011
- Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndromeBlood, 2011
- Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemiaNature Genetics, 2011
- The human syndrome of dendritic cell, monocyte, B and NK lymphoid deficiencyJournal of Experimental Medicine, 2011
- Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasiaBlood, 2010
- Juvenile myelomonocytic leukemia: A report from the 2nd International JMML SymposiumLeukemia Research, 2009
- Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemiaThe Lancet Oncology, 2009